Author(s):
Shubham Gautam, Rimpy, Jaishree Sharma, Deepak Ranga, Surender Verma
Email(s):
svpharma.kuk@gmail.com
DOI:
10.52711/2231-5713.2026.00012 
Address:
Shubham Gautam, Rimpy, Jaishree Sharma, Deepak Ranga, Surender Verma*
Institute of Pharmaceutical Sciences, Kurukshetra University, Kurukshetra - 136119 (Haryana), India.
*Corresponding Author
Published In:
Volume - 16,
Issue - 1,
Year - 2026
ABSTRACT:
Background: Helicobacter pylori (H. pylori) infection is a major cause of gastric ulcers and gastric cancer. Conventional antibiotic therapy often faces limitations due to resistance and side effects. Probiotics such as Lactobacillus acidophilus can improve gastric health and enhance therapeutic efficacy. The present study aimed to develop and optimize an esomeprazole–probiotic mucoadhesive microsphere formulation for gastric delivery.
Materials and Methods: Mucoadhesive microspheres were prepared using sodium alginate and Carbopol 934 by the ionic gelation method, with calcium chloride as the crosslinking agent. A Box–Behnken design was employed to optimize key formulation variables (polymer concentration and stirring speed) with entrapment efficiency, particle size, and yield as responses. The formulations were characterized for entrapment efficiency, probiotic survival in simulated gastric fluid (pH 2), swelling index, mucoadhesion on rat gastric mucosa, FTIR compatibility, SEM morphology, and in vitro drug release kinetics. Results: The optimized formulations (OM1 and OM2) demonstrated high entrapment efficiency (>94%), strong mucoadhesive strength, and excellent probiotic stability in acidic gastric conditions. FTIR confirmed drug–polymer compatibility, and SEM revealed spherical porous microspheres. In vitro release studies showed sustained drug release over 12h, following zero-order and Korsmeyer–Peppas kinetics. Conclusion: Esomeprazole–probiotic microspheres exhibited significant probiotic protection, controlled drug release, and good gastric mucoadhesion, indicating their potential as a promising alternative strategy for the management of H. pylori–induced gastric disorders.
Cite this article:
Shubham Gautam, Rimpy, Jaishree Sharma, Deepak Ranga, Surender Verma. Probiotics - based Dosage form Development against H. Pylori induced Gastric Disorders. Asian Journal of Pharmacy and Technology. 2026; 16(1):81-0. doi: 10.52711/2231-5713.2026.00012
Cite(Electronic):
Shubham Gautam, Rimpy, Jaishree Sharma, Deepak Ranga, Surender Verma. Probiotics - based Dosage form Development against H. Pylori induced Gastric Disorders. Asian Journal of Pharmacy and Technology. 2026; 16(1):81-0. doi: 10.52711/2231-5713.2026.00012 Available on: https://ajptonline.com/AbstractView.aspx?PID=2026-16-1-12
10. REFERENCES:
1. Shirani M, Pakzad R, Haddadi MH, Akrami S, Asadi A, Kazemian H, et al. The global prevalence of gastric cancer in Helicobacter pylori-infected individuals: a systematic review and meta-analysis. BMC Infect Dis 2023; 23:543. https://doi.org/10.1186/s12879-023-08504-5.
2. Thulluru A, Basha SS, Rao CB, Kumar ChSP, Mahammed N, Kumar KS. Optimization of HPMC K100M and Sodium Alginate Ratio in Metronidazole Floating Tablets for the Effective Eradication of Helicobacter pylori. Asian Journal of Pharmacy and Technology 2019; 9:195. https://doi.org/10.5958/2231-5713.2019.00033.3.
3. Yang Z, Zhou Y, Han Z, He K, Zhang Y, Wu D, et al. The effects of probiotics supplementation on Helicobacter pylori standard treatment: an umbrella review of systematic reviews with meta-analyses. Sci Rep 2024; 14:10069. https://doi.org/10.1038/s41598-024-59399-4.
4. Lokhande S, More S, Raje V. A Systematic Study of Probiotics-An Update Review. Asian Journal of Pharmacy and Technology 2018; 8:149. https://doi.org/10.5958/2231-5713.2018.00024.7.
5. Ali M, Pandit V, Jain M, Dhar K. Mucoadhesive microparticulate drug delivery system of curcumin against Helicobacter pylori infection: Design, development and optimization. J Adv Pharm Technol Res 2014; 5:48. https://doi.org/10.4103/2231-4040.126996.
6. Neelam S, Meenakshi B. Formulation And Evaluation Of Polymeric Microspheres Using Box–Behnken Design. Asian Journal of Pharmaceutical and Clinical Research 2022:47–55. https://doi.org/10.22159/ajpcr.2022.v15i10.45250.
7. Mohanty D, Zafar A, Jafar M, Upadhyay AK, Haque MA, Gupta JK, et al. Development, In-Vitro Characterization and Preclinical Evaluation of Esomeprazole-Encapsulated Proniosomal Formulation for the Enhancement of Anti-Ulcer Activity. Molecules 2022; 27:2748. https://doi.org/10.3390/molecules27092748.
8. Verma S, Kumar Singh P, Panwar J, Kumar Shukla V, Easwari TS. Design and Characterisation of Gentamicin Floating Microspheres as Potential Drug Carrier for the treatment of Intra-Abdominal Infection. Asian Journal of Pharmaceutical Research 2024:133–40. https://doi.org/10.52711/2231-5691.2024.00023.
9. Mahurkar N, Sayeed Ul Hasan SM. Synergistic Antiulcer Effect of Melatonin and Esomeprazole Combination in Pylorus Ligation, Ethanol, Aspirin induced Peptic Ulcers. Asian Journal of Pharmaceutical Research 2015; 5:10. https://doi.org/10.5958/2231-5691.2015.00002.7.